BENSON MBOCHE: Open Payments
NPI 1699317719 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 25 payments from 7 companies in 2025. Trend: 2023 $370 · 2024 $835 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $153 |
| ABBVIE INC. | 12 | $153 |
| Lundbeck LLC | 4 | $95 |
| Janssen Pharmaceuticals, Inc | 1 | $40 |
| E.R. Squibb & Sons, L.L.C. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Alkermes, Inc. | 1 | $18 |
Products named: INGREZZA, VRAYLAR, ABILIFY ASIMTUFII, INVEGA SUSTENNA, COBENFY, ABILIFY MAINTENA, ARISTADA.
Industry payments across MD — which companies pay providers there.
